PRF Technologies PRFX
NASDAQ PRFX
$0.93 -0.03 (-3.23%)
At close: Sep 22, 2026 · 4:00 PM EDT

PRF Technologies (PRFX) Cash from Investing Activities (2021 - 2024)

PRF Technologies' (PRFX) quarterly Cash from Investing Activities came in at -$5000.0 in Q2 2024, up 99.5% on a YoY basis from -$2506.3 in Q3 2023, and up 28.57% quarter-over-quarter from -$7000.0 in Q1 2024.

Analysis

PRF Technologies (PRFX) Cash from Investing Activities (2021 - 2024) Analysis & Trends

PRF Technologies (PRFX) has reported Cash from Investing Activities for 4 consecutive years, with -$5000.0 the latest figure, recorded in Q2 2024.

  • For the quarter ending Q2 2024, Cash from Investing Activities rose 99.5% year-over-year to -$5000.0; the trailing twelve-month figure through Jun 2024 stood at $979000.0 (up 197.61% YoY), and the FY2025 full-year result was -$982000.0, down 7453.85% from the prior year.
  • Cash from Investing Activities climbed to -$5000.0 in Q2 2024 per PRFX's latest filing, from -$7000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $6.0 million in Q1 2023 and bottomed at -$6.0 million in Q3 2022.
  • Historically, Cash from Investing Activities has averaged -$6166.7 across 4 years, with a median of -$6500.0 in 2021.
  • The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities tumbled 100416.67% in 2022, then soared 3467.86% in 2023.
  • Over 4 years, Cash from Investing Activities stood at -$28000.0 in 2021, then jumped by 200.0% to $28000.0 in 2022, then jumped by 3467.86% to $999000.0 in 2023, then slumped by 100.5% to -$5000.0 in 2024.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered -$5000.0, -$7000.0, and $999000.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Teva Pharmaceutical Industries 46.72 Bn 43.07 Bn 2.15 Bn -491.00 Mn
2 Viatris 19.64 Bn 18.75 Bn 1.46 Bn -51.60 Mn
3 Dr Reddys Laboratories 10.36 Bn 10.22 Bn 396.53 Mn 40.52 Mn
4 Amneal Pharmaceuticals 6.44 Bn 6.39 Bn 334.51 Mn -122.74 Mn
5 Bausch Health Companies 2.11 Bn 1.24 Bn 2.10 Bn -93.00 Mn
6 Ani Pharmaceuticals 1.88 Bn 1.52 Bn 165.89 Mn -3.05 Mn
7 Alvotech 1.83 Bn 1.69 Bn 2.56 Mn -44.77 Mn
8 Amphastar Pharmaceuticals 1.04 Bn 751.07 Mn 93.47 Mn 44.87 Mn
9 Fennec Pharmaceuticals 382.22 Mn 340.97 Mn 17.15 Mn -
10 PRF Technologies 622,054.07 -10.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -5,000.00
Mar 31, 2024 -7,000.00
Dec 31, 2023 999,000.00
Sep 30, 2023 -8,000.00
Jun 30, 2023 -1.00 Mn
Mar 31, 2023 6.00 Mn
Dec 31, 2022 28,000.00
Sep 30, 2022 -6.03 Mn
Dec 31, 2021 -28,000.00
Sep 30, 2021 -6,000.00
Jun 30, 2021 -3,000.00
Mar 31, 2021 -13,000.00
API Access

PRF Technologies Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=PRFX&period=max&api_key=YOUR_API_KEY